Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Cash Flow (2016 - 2023)

Sonoma Pharmaceuticals (SNOA) has 4 years of Net Cash Flow data on record, last reported at $1.3 million in Q1 2013.

  • For Q1 2013, Net Cash Flow rose 181.28% year-over-year to $1.3 million; the TTM value through Mar 2013 reached $4.5 million, up 580.38%, while the annual FY2025 figure was $2.9 million, 495.3% up from the prior year.
  • Net Cash Flow reached $1.3 million in Q1 2013 per SNOA's latest filing, up from -$1.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $3.9 million in Q3 2012 and bottomed at -$1.7 million in Q4 2012.
  • Average Net Cash Flow over 4 years is $139833.3, with a median of $49000.0 recorded in 2010.
  • The widest YoY moves for Net Cash Flow: up 389.44% in 2012, down 397.17% in 2012.
  • A 4-year view of Net Cash Flow shows it stood at -$684000.0 in 2010, then soared by 294.59% to $1.3 million in 2011, then plummeted by 228.93% to -$1.7 million in 2012, then soared by 174.88% to $1.3 million in 2013.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $1.3 million in Q1 2013, -$1.7 million in Q4 2012, and $3.9 million in Q3 2012.